Thoroughbred Financial Services LLC Sells 1,840 Shares of Intuitive Surgical, Inc. $ISRG

Thoroughbred Financial Services LLC lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 26.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,012 shares of the medical equipment provider’s stock after selling 1,840 shares during the quarter. Thoroughbred Financial Services LLC’s holdings in Intuitive Surgical were worth $2,241,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in shares of Intuitive Surgical by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock worth $15,026,776,000 after purchasing an additional 263,828 shares during the last quarter. State Street Corp grew its stake in Intuitive Surgical by 1.2% during the second quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock worth $8,451,223,000 after buying an additional 182,871 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Intuitive Surgical by 1.4% in the second quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after acquiring an additional 109,904 shares during the last quarter. Norges Bank acquired a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $2,569,260,000. Finally, Invesco Ltd. grew its position in Intuitive Surgical by 4.8% during the 2nd quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock worth $2,402,488,000 after acquiring an additional 201,159 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, VP Fredrik Widman sold 133 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This represents a 16.77% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Myriam Curet sold 421 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the transaction, the executive vice president directly owned 409 shares in the company, valued at approximately $202,438.64. This represents a 50.72% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 56,189 shares of company stock worth $30,785,441. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent analyst reports. Citigroup reissued a “neutral” rating and issued a $590.00 price objective (down from $635.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Piper Sandler reiterated an “overweight” rating and set a $620.00 price target (up from $610.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research report on Friday, January 23rd. HSBC upped their target price on shares of Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research report on Monday, January 26th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $615.86.

Intuitive Surgical Stock Performance

ISRG opened at $506.17 on Thursday. The firm’s fifty day moving average is $532.31 and its two-hundred day moving average is $511.29. The firm has a market cap of $179.76 billion, a PE ratio of 64.15, a price-to-earnings-growth ratio of 3.83 and a beta of 1.65. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business’s revenue was up 18.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.21 earnings per share. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.